PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: quiz answers

FSRH Guideline Contraception for Women Aged Over 40 Years

FSRH Guideline Contraception for Women Aged Over 40 Years August 2017 (Amended September 2019)| FSRH Title Contraception for Women Aged Over 40 Years Author/ publisher Faculty of Sexual & Reproductive Healthcare Publication date August 2017 (Amended September 2019)Superseded document Contraception for Women Aged Over 40 Years (July 2010) Review date October 2022 Available online Details of changes to original guidance document Since this Guideline was first published, the following changes have been made:October 2017:Section , with amenorrhoea added to Women over 50 using POC Section , with amenorrhoea added to Women over 50 using POC Table 8, with amenorrhoea added to If a woman over 50 wishes to stop before age 55 September 2019: Throughout the Guideline , where '52mg LNG-IUS' is used without clarification, it applies to any 52mg LNG-IUS.

myocardial infarction (MI) and has not been shown to affect bone mineral density (BMD). ... bone density due to the hypoestrogenic effects of DMPA but the evidence suggests that this initial bone loss is not repeated or worsened by onset of menopause. B :

Fullscreen Download

Tags:

  Mineral, Bone, Density, Bone mineral density, Bone density

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of FSRH Guideline Contraception for Women Aged Over 40 Years

Documents from same domain

FSRH Guideline Combined Hormonal Contraception

www.fsrh.org

9.1 Heavy menstrual bleeding 23 9.2 Menstrual pain 23 9.3 Acne 24 9.4 Premenstrual symptoms 24 9.4.1 EE/DRSP COC for management of premenstrual symptoms 24 9.4.2 Other COC for management of premenstrual symptoms 24 9.4.3 Extended COC regimens for management of premenstrual symptoms 24 9.5 Vasomotor symptoms 25 9.6 Bone health 25

  Heavy, Bleeding, Menstrual, Heavy menstrual bleeding

FSRH Guideline Emergency Contraception

www.fsrh.org

MHRA Medicines and Healthcare products Regulatory Agency OR odds ratio PEPSE post-exposure HIV prophylaxis after sexual exposure PGD patient group direction POP progestogen-only pill RCT randomised control trial SPC Summary of Product Characteristics SRH sexual and reproductive healthcare STI sexually transmitted infection

  Product, Regulatory, Agency, Medicine, Healthcare, Medicines and healthcare products regulatory agency

FSRH Guideline Progestogen-only Implant

www.fsrh.org

8.1 Medical eligibility 8 8.2 Assessment of factors that could affect contraceptive effectiveness 10 9 Non-contraceptive benefits associated with use of the etonogestrel implant 10 9.1 Dysmenorrhoea 10 9.2 Heavy menstrual bleeding 10 9.3 Endometriosis 11 9.4 Endometrial protection in polycystic ovary syndrome 11

  Eligibility, Guidelines, Medical, Only, Implants, Medical eligibility, Fsrh guideline progestogen only implant, Fsrh, Progestogen

FSRH Guideline Quick Starting Contraception April 2017

www.fsrh.org

UKMEC UK Medical Eligibility for Contraceptive Use UPA-EC ulipristal acetate (for emergency contraception) ... Criteria for reasonably excluding pregnancy are outlined in . Section 5. Quick start of combined hormonal contraception (CHC), the progestogen-only pill (POP), the

  Eligibility, Medical, Criteria, Combined, Ukmec, Ukmec uk medical eligibility

OF SEXUAL &REPRODUCTIVE HEALTHCARE

www.fsrh.org

With typical use the failure rate is approximately 6%. Health professionals should be familiar with the most up-to-date UK Medical Eligibility Criteria for progestogen-only injectable contraception. Amenorrhoea or reduced bleeding is common in progestogen-only injectable users and may benefit women with menstrual problems.

  Eligibility, Medical, Criteria, Medical eligibility criteria

Faculty of Sexual & Reproductive Healthcare Clinical Guidance

www.fsrh.org

Eligibility Health professionals should be familiar with the UK Medical Eligibility Criteria for intrauterine methods. Efficacy Women should be advised of the very low failure rates associated with use of intrauterine contraception (IUC). The most effective methods of IUC are the levonorgestrel intrauterine system (LNG-IUS)

  Eligibility, Medical, Criteria, Medical eligibility criteria

Faculty of Sexual & Reproductive Healthcare Clinical Guidance

www.fsrh.org

A comparative trial of the DSG versus LNG-only pill reported an overall failure rate for the LNG pill of 1.55 per 100 woman-years [95% confidence interval (CI) 0.422–3.963] and for the DSG pill 0.41 per 100 woman-years (95% CI 0.085–1.204). The failure rates were not found to be

  Pill

UK MEDICAL ELIGIBILITY CRITERIA - FSRH

www.fsrh.org

• Are intended to be applied to use of the method of contraception for contraceptive purposes. Where a method of contraception is used for a non-contraceptive indication [e.g. management of heavy menstrual bleeding (HMB)] the risk/benefit profile and eligibility criteria may differ.

  Eligibility, Medical, Criteria, Contraceptive, Uk medical eligibility criteria

Faculty of Sexual & Reproductive Healthcare Clinical Guidance

www.fsrh.org

problematic bleeding to identify the possibility of an underlying cause. Hormonal contraception users with problematic bleeding who are at risk of sexually transmitted infections (STIs) should be tested for Chlamydia trachomatis as a minimum. Testing for Neisseria gonorrhoea will depend on sexual risk, local prevalence and availability of dual ...

  Problematic

Faculty of Sexual & Reproductive Healthcare Clinical …

www.fsrh.org

NCSP National Chlamydia Screening Programme NET-EN norethisterone enantate ... Since this set of guideline was first published, the following changes have been made: May2019 - Removed Appendix 5 and 7. Updated Appendix 6. Updated section ...

  Guidelines, Screening, Sexual, Clinical, National, Faculty, Healthcare, Reproductive, Faculty of sexual amp reproductive healthcare clinical

Related documents

Healthy Bones For Life - National Osteoporosis Foundation

www.bonehealthandosteoporosis.org

7. People with low bone density are more likely to break a bone compared to people with normal bone density. 8. If you have low bone mass, your doctor will evaluate you to see if you need medication. KEY POINTS 38.6% 51.7% 9.8% LOW BONE MINERAL DENSITY Normal Osteopenia Osteoporosis

  Mineral, Bone, Density, Bone mineral density, Bone density

Bone (Mineral) Density Studies (NCD 150.3) - …

www.uhcprovider.com

Bone strength and fracture risk using finite element analysis of functional data, and bonemineral - density, utilizing data from a computed tomography scan; retrieval and transmission of the scan data, assessment of bone strength and fracture risk and bone mineral density, interpretation and report (Effective 07/01/2019)

  Studies, Mineral, Bone, Density, Bone mineral density, Density studies

Bone mineral density (BMD) and tissue mineral density …

medicine.temple.edu

Bone mineral density (BMD) is defined as the volumetric density of calcium hydroxyapatite (CaHA) in a biological tissue -in terms of g.cm 3. It is calibrated by means of phantoms with known density of CaHA. Bone mineral density can refer to two different measurements:

  Mineral, Bone, Density, Mineral density, Bone mineral density

Related search queries

Bone density, Bone, Bone mineral density, Bone (Mineral) Density Studies NCD, Density, Mineral density